Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.
Research Interests

Papers共 23 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Successful treatment with tislelizumab plus chemotherapy for SMARCA4-deficient undifferentiated tumor: a case report
Wen Dong, Anli Dai,Zhijun Wu, Jiangtao Wang,Tao Wu, Yangfeng Du, Wei Tian,Jiang Zheng,Yan Zhang, Hongming Wang,Juan Cai,Susu Dong,
Frontiers in immunology (2024): 1371379-1371379
Cited0Views0WOSBibtex
0
0
SALIRI-based (raltitrexed plus irinotecan) therapy as a second-line treatment for patients with metastatic colorectal cancer (SALLY): A prospective, multicenter, non-interventional, registry study
Shuqui Qin, Jin Li, Aiping Zhou, Yanqiao Zhang, Xianglin Yuan, Liangjun Zhu, Baoli Qin, Shan Zeng, Lin Shen, Ying Yuan, Weibo Wang, Jun Liang,
Cancer communications (London, England) (2024)
Cited0Views0WOSBibtex
0
0
Two Enhances the Cisplatin Sensitivity of Cervical Cancer Cells via Suppression of c-MET Expression
Ziqin Chen,Zemin Xiao, Wei Tian, Zongjuan Li,Tao Wu
Iranian journal of public healthno. 7 (2023): 1476-1486
Cited0Views0WOSBibtex
0
0
Neoadjuvant osimertinib and chemotherapy for stage IIIA primary pulmonary carcinosarcoma with EGFR 19DEL mutation: A case report
Hongming Wang,Zhijun Wu, Yangfeng Du,Tao Wu, Wei Tian,Wen Dong, Juan Cai, Jiang Zheng, Yan Zhang, Shiyan Li, Wei Xu,Jing Qin,
FRONTIERS IN ONCOLOGY (2023)
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics
  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn